Drug News

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for golodirsen (SRP-4053; Sarepta), a treatment designed for patients with Duchenne muscular dystrophy (DMD) who have genetic mutations that are amenable to exon 53 skipping.

news

Preventive mastectomy that preserves the nipple and surrounding skin may be as effective in preventing breast cancer in high-risk women as more invasive surgeries, according to a study presented at the annual meeting of the American Society of Breast Surgeons (ASBS).

news

reatment with the selective noradrenalin-reuptake-inhibitor atomoxetine is not associated with increased suicide risk compared with stimulant use in children and adolescents, according to a study published online in Pediatrics.